FamiCord Group, the leading stem cell bank in Europe and number 3 worldwide, is a publicly traded biotech group consisting of European biotech companies Vita 34 (Germany), P.B.K.M. (Poland), Crioestaminal (Portugal), Smart Cells (UK) and over 30 other subsidiaries. Founded in 2002, FamiCord Group is present in over 35 countries in Europe and the Middle East. The group deals with the storage of biological material and the manufacture, development, and approval of cell therapeutics for clinical use. More than 850,000 cryopreserved umbilical cord blood and tissue deposits and more than 4,200 patients treated with stem cells in clinical studies, experimental and standard therapies testify to the extraordinary expertise in the field of stem cell banking and clinical application. FamiCord Deutschland GmbH deals with the manufacture, development, and approval of ATMP for clinical use in humans.

FGK Clinical Research is a full-service CRO based in Germany, with its headquarters in Munich, a branch office in Berlin, and subsidiaries in Czech Republic, Poland, and Hungary. Since 2002, FGK has been managing clinical studies of phases I to IV from planning to the final report throughout Europe, specializing in cooperation with small to medium-sized biotech, medical device or pharmaceutical companies. The management of FGK sees their innovative therapy approaches as a special challenge. FGK has experience in every important medical indications, including particular focuses in oncology, cardiology, neurology, dermatology, and gastroenterology. The extensive experience of its 200 employees and an owner-managed company structure with flat hierarchies enable FGK to support these complex projects flexibly and personally. At the same time, FGK is constantly expanding its expertise and keeps pace with the increasing digitalization in the field of clinical studies.

Green Elephant Biotech GmbH, based in Giessen (Germany), was formed in 2021 as a spin-off from the Technical University of Hesse (THM) in the field of bioprocess technology. The company was founded by Felix Wollenhaupt and Dr. Joel Eichmann with the aim of producing laboratory supplies from sustainable materials and thus supporting research and production companies in the biotech and pharmaceutical industries in reducing their CO2 emissions.

Kiefel GmbH is a dependable partner for innovative & reliable production machine solutions for the medical, pharmaceutical, and bioprocess industry, which demands highest standards. Kiefel's systems for producing bioprocess-, pharmaceutical- and medical-specialty bags, as well as special application units ensure high-quality products in these important sectors.
Presentation title: "Reliable & innovative machine solutions for the bioprocess-, medical- and pharmaceutical industry".

LenioBio is a protein expression platform company committed to advancing transformative technology for the discovery, development, and large-scale production of proteins, unconstrained by the limitations of the cell.
LenioBio was established as a legal entity in Germany in September 2016, with offices in Dusseldorf and R&D and production labs in Aachen.

Lipotype is the leading lipidomics provider and your access to lipids and lipid metabolism data. Our mass spectrometry-based platform can be applied to all biological samples and covers more than 4200 lipids – the broadest lipidomics coverage.
It is robust and reproducible, and combines reliable data quality control with state-of-the-art data visualization and statistical analyses.